+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A kinetic study of [131I] iodide and [99mTc] pertechnetate in thyroid carcinoma to explain a scan discrepancy: case report

A kinetic study of [131I] iodide and [99mTc] pertechnetate in thyroid carcinoma to explain a scan discrepancy: case report

Journal of Nuclear Medicine 18(8): 796-798

A study of unusual 1-131 and [99mTc] pertechnetate kinetics was carried out in a case of thyroid carcinoma. A major discrepancy in the handling of iodide, probably resulting from a deficient iodine organification process, was shown.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 039069184

Download citation: RISBibTeXText

PMID: 874166

Related references

High pre-therapy [99mTc]pertechnetate thyroid uptake, thyroid size and thyrostatic drugs: predictive factors of failure in [131I]iodide therapy in Graves' disease. Nuclear Medicine Communications 26(11): 957-963, 2005

Thyroid carcinoma presenting as a pertechnetate "hot" nodule, but without 131I uptake: case report. Journal of Nuclear Medicine 17(1): 22-23, 1976

Clinical value of 99mTc-MIBI imaging, 131I whole body scan and HTG determination for the follow-up of patients with differentiated thyroid carcinoma after 131I therapy. Hua Xi Yi Ke Da Xue Xue Bao 30(4): 437-439, 1999

Papillary thyroid carcinoma concentrating both Tc-99m sodium pertechnetate and I-131 iodide. Case report and review of the literature. Clinical Nuclear Medicine 16(7): 497-500, 1991

Scintigraphic visualization of a distant metastasis from a follicular thyroid carcinoma using 99mTc pertechnetate prior to thyroidectomy. Case report. Rofo 144(1): 107-109, 1986

Altered 99mTc-pertechnetate distribution in a thyroid scan after 99mTc-Sn pyrophosphate administration. Clinical Nuclear Medicine 4(7): 277-282, 1979

Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo. European Journal of Nuclear Medicine and Molecular Imaging 34(5): 638-650, 2007

Unusual initial manifestation of metastatic follicular carcinoma of the thyroid with thyrotoxicosis diagnosed by technetium Tc 99m pertechnetate scan: case report and review of literature. Endocrine Practice 15(5): 458-462, 2009

Early assessment of amputation level in frostbite by 99mTc-pertechnetate scan. Case report. Acta Chirurgica Scandinavica 154(5-6): 403-405, 1988

99mTc pertechnetate thyroid scan leads to serendipitous detection of metastatic thyroid cancer. Clinical Nuclear Medicine 37(6): 604-606, 2012

Clinical approach in patients with metastatic differentiated thyroid carcinoma and negative 131I whole body scintigraphy: importance of 99mTc MIBI scan combined with high resolution neck ultrasonography. Tumori 85(2): 122-127, 1999

Comparative accumulation of 99mTc and 131I in thyroid nodules: case report. Journal of Nuclear Medicine 18(4): 346-347, 1977

99mTc-pertechnetate-avid metastases from differentiated thyroid cancer are prone to benefit from 131I therapy: A prospective observational study. Medicine 96(33): E7631, 2017

Increased 99mTc Pertechnetate Uptake But Unimpressive 131I Activity in the Metastatic Mediastinal Lymph Nodes in a Thyroid Cancer Patient. Clinical Nuclear Medicine 44(2): 176-178, 2019

Low-activity 124I-PET/low-dose CT versus 99mTc-pertechnetate planar scintigraphy or 99mTc-pertechnetate single-photon emission computed tomography of the thyroid: a pilot comparison. Clinical Nuclear Medicine 38(10): 770-777, 2013